Healthcare Industry News: IRIDEX
News Release - October 17, 2007
Theodore A. Boutacoff Appointed President & CEO of IRIDEXMOUNTAIN VIEW, Calif., Oct. 17 (HSMN NewsFeed) -- IRIDEX Corporation (Nasdaq: IRIX ) announced today that Barry Caldwell has resigned as the Company's President and Chief Executive Officer, and as a member of the Board of Directors, effective as of October 16, 2007. The Board of Directors has appointed Theodore A. Boutacoff, who is currently a member and Chairman of the Board of Directors, to serve as the Company's President and Chief Executive Officer. Prior to Mr. Caldwell's two year tenure, Mr. Boutacoff had been the Company's President and Chief Executive Officer since co-founding the Company in 1989.
IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 97 independent distributors into 107 countries.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.